技源集团：HMB领跑全球，精准营养扬帆起航-20260204

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company, Jiyuan Group, is positioned as a leader in the HMB market, with a strong focus on precision nutrition and a robust growth trajectory anticipated through 2027 [8][10]. - The report highlights the company's significant market share in HMB, projected at approximately 53.34% globally by 2024, and emphasizes the potential for expansion in medical nutrition and sports nutrition sectors [8][10]. - The health supplement industry in China is expected to maintain a high single-digit growth rate from 2025 to 2027, driven by aging demographics and new consumer trends [8][10]. Summary by Sections 1. Company Overview - Jiyuan Group specializes in health supplement raw materials and formulations, with a projected revenue of 1 billion CNY and a net profit of 175 million CNY for 2024, reflecting a CAGR of 10% and 25% respectively from 2019 to 2024 [8][14]. - The company’s product revenue is expected to be composed of 65% raw materials and 35% formulations by 2024, with HMB, glucosamine, and chondroitin sulfate being key products [8][14]. 2. Industry Analysis - The health supplement industry in China is experiencing robust growth, with the market size expected to increase from 70.1 billion CNY in 2010 to 232.3 billion CNY in 2024, representing a CAGR of 8.93% [40][41]. - The report notes that the aging population and rising health awareness are foundational drivers for long-term demand in the health supplement sector [43][45]. 3. Business Model and Strategy - Jiyuan Group has established a comprehensive business model that integrates raw material production and contract manufacturing, providing a competitive edge in cost efficiency [54]. - The company is focusing on precision nutrition, which is projected to be a significant growth area, with the global market expected to reach approximately 15.8 billion USD by 2025 [56][60]. 4. Financial Projections - Revenue forecasts for Jiyuan Group are set at 10.83 billion CNY for 2025, 13.12 billion CNY for 2026, and 15.69 billion CNY for 2027, with corresponding growth rates of 8%, 21%, and 20% [8][10]. - The expected net profit for the same years is projected at 1.71 billion CNY, 2.35 billion CNY, and 2.91 billion CNY, with growth rates of -2%, 37%, and 24% respectively [8][10].